Kyverna Therapeutics, Inc. (KYTX) Stock price, Description, News & Info

#Thinksabio latest news

Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis